(NYSE: BAK) Braskem Sa's forecast annual revenue growth rate of 5.74% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 2.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.36%.
Braskem Sa's revenue in 2025 is $13,439,409,722.On average, 2 Wall Street analysts forecast BAK's revenue for 2025 to be $11,070,745,469,975, with the lowest BAK revenue forecast at $10,806,861,704,842, and the highest BAK revenue forecast at $11,334,629,235,107. On average, 2 Wall Street analysts forecast BAK's revenue for 2026 to be $12,454,323,582,117, with the lowest BAK revenue forecast at $11,727,198,288,804, and the highest BAK revenue forecast at $13,181,448,875,430.
In 2027, BAK is forecast to generate $12,175,149,370,728 in revenue, with the lowest revenue forecast at $12,175,149,370,728 and the highest revenue forecast at $12,175,149,370,728.